In a series of 29 patients with symptomatic post–COVID-19, all developed antibodies directed against different G-protein-coupled receptors (alpha adrenoreceptor, beta-adrenoreceptor, angiotensin II, nociceptin, and muscarinic) known to be able to disturb the balance of neuronal and vascular processes (72). This evidence concerns the gene PNOC and COVID-19.